Back

Percutaneous mitral valve therapies in HF: where do we stand?

5 December 2019 (09:15 - 09:37)
Organised by:
Congress Presentation Part of: Valvular heart disease and heart failure: burning issues Valvular Heart Disease EACVI Premium Access EuroEcho 2019

About the speaker

Photo
Associate Professor Ozge Ozden Kayhan

Bahcelievler Memorial Hospital, Istanbul (Turkiye)

3 More presentations in this session

Presentation thumbnail
VHD and heart failure: disease of the valve or the ventricle?
Assistant Professor T. Podlesnikar (Maribor, SI)
Slides Video
Presentation thumbnail
VHD and heart failure: lessons learned from atria.
Doctor G. Mandoli (Siena, IT)
Presentation thumbnail
Tricuspid regurgitation and right heart failure: how to improve our diagnostics?
Associate Professor S. Mihaila Baldea (Bucharest, RO)
Slides Video

Access the full session

Session thumbnail
Valvular heart disease and heart failure: burning issues

The Event

Event poster

EuroEcho 2019

5 December 2019 09:15 CET
You may be interested in
thumbnail
Congress Session
Interventions for heart failure: mitral, tricuspid, and atrial shunt therapies
18 May 2025
thumbnail
Congress Presentation
Trans-catheter mitral valve repair in the elderly and very elderly patients with focus on postprocedural safety and 1year-effectiveness
28 August 2022
thumbnail
Congress Presentation
How imaging guides decision making about percutaneous interventions - discussion.
8 December 2022
thumbnail
Webinar
Structural heart interventions in aortic valvular disease - IC Core Curriculum 2
4 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources